These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Medications for the treatment of Alzheimer's disease. Lampley-Dallas VT J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease. Crismon ML Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465 [TBL] [Abstract][Full Text] [Related]
6. New drugs for Alzheimer's disease in Japan. Takeda M; Tanaka T; Okochi M Psychiatry Clin Neurosci; 2011 Aug; 65(5):399-404. PubMed ID: 21851448 [No Abstract] [Full Text] [Related]
7. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease. Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699 [TBL] [Abstract][Full Text] [Related]
8. New therapeutic approaches to Alzheimer's disease. Schneider LS J Clin Psychiatry; 1996; 57 Suppl 14():30-6. PubMed ID: 9024334 [TBL] [Abstract][Full Text] [Related]
9. The impact of journal advertisements on prescribers of cholinesterase inhibitors. Sauer J; Howard R Int J Geriatr Psychiatry; 2002 Oct; 17(10):976-8. PubMed ID: 12325061 [No Abstract] [Full Text] [Related]
12. New therapeutic approaches to cognitive impairment. Schneider LS J Clin Psychiatry; 1998; 59 Suppl 11():8-13. PubMed ID: 9731544 [TBL] [Abstract][Full Text] [Related]
13. Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine? Sharma JC Int J Clin Pract; 2002; 56(6):414-5. PubMed ID: 12166537 [No Abstract] [Full Text] [Related]
14. Use of cholinesterase inhibitors for treatment of Alzheimer disease. Hake AM Cleve Clin J Med; 2001 Jul; 68(7):608-9, 613-4, 616. PubMed ID: 11453078 [TBL] [Abstract][Full Text] [Related]
15. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko]. Gasser US; Gasser T MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165 [No Abstract] [Full Text] [Related]
16. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population. Prasher VP Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527 [TBL] [Abstract][Full Text] [Related]
17. A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease. Alisky JM J Alzheimers Dis; 2003 Dec; 5(6):477-8. PubMed ID: 14757938 [No Abstract] [Full Text] [Related]
18. The new cholinesterase inhibitors for Alzheimer's disease, Part 1: their similarities are different. Stahl SM J Clin Psychiatry; 2000 Oct; 61(10):710-1. PubMed ID: 11078030 [TBL] [Abstract][Full Text] [Related]